You are here

Pfizer

Naturally-Derived Cancer Drugs Provide Clues As To How Microbiome May Cause Chemotherapy Resistance

Forbes

Fri, 06/22/18 - 10:18 am

Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx

Yahoo/Zacks.com

Tue, 06/19/18 - 10:19 pm

Myriad Genetics

BRACAnalysis CDx

Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers

Motley Fool

Fri, 06/15/18 - 07:04 pm

Viking Therapeutics

Madrigal Pharmaceuticals

Bristol-Myers Squibb

Gilead Sciences

ViiV Healthcare reports positive results for late-stage HIV trials

Marketwatch

Thu, 06/14/18 - 09:19 am

ViiV Healthcare

clinical trials

GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report

Fierce Pharma

Tue, 06/12/18 - 11:22 am

Can This Pharma's $14 Billion Bet Succeed?

Motley Fool

Tue, 06/12/18 - 09:39 am

A Story Of Devastation And Rebirth -- The Former Pfizer Research Labs In Ann Arbor

Forbes

Mon, 06/11/18 - 09:34 am

Pfizer wins appeal against UK fine for epilepsy drug price hike

Yahoo/Reuters

Thu, 06/7/18 - 10:46 pm

Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission

CP Wire

Thu, 06/7/18 - 12:07 pm

BRCA-mutant breast cancer

metastatic breast cancer

priority review

Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission

Thu, 06/7/18 - 12:04 pm

BRCA-mutant breast cancer

Pfizer adds $600M to its venture group, with a special focus on the neurosciences field it just retreated from

Endpoints

Wed, 06/6/18 - 11:29 am

BIO18: Pfizer's Bourla on volume vs. value

Biopharma Dive

Mon, 06/4/18 - 10:04 pm

Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

CP Wire

Fri, 06/1/18 - 10:10 am

Pfizer's Xeljanz jumps into ulcerative colitis fray with best-case FDA approval

Fierce Pharma

Thu, 05/31/18 - 10:58 am

ulcerative colitis

With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?

Endpoints

Tue, 05/29/18 - 09:22 pm

Gilead Sciences

FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications

CP Wire

Tue, 05/29/18 - 10:37 am

metastatic non-small cell lung cancer

breakthrough therapies

anaplastic large-cell lymphoma

FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications

Tue, 05/29/18 - 10:14 am

non-small cell lung cancer

anaplastic large-cell lymphoma

Pfizer lies behind Mylan’s issues with Epipen

GoinPharma

Mon, 05/28/18 - 01:29 pm

Kickback Allegation Settlements Pile Up for Pharmaceutical Companies

RAPS.org

Sat, 05/26/18 - 09:19 am

Jazz Pharmaceuticals

Valeant Pharmaceuticals

Biopharma M&A: You Ain’t Seen Nothing Yet

Barron's

Fri, 05/25/18 - 09:32 am

Gilead Sciences

Pages